1522
Vol. 53, No. 12
the Hiroshima Prefectural Forestry Research Center. Leaves of A. japonica
were collected in September 2001 in the mountainous northern part of Hi-
roshima prefecture, Japan.
10.6 Hz, xyl-5), 3.28 (1H, t, Jꢂ9.2 Hz, xyl-3), 3.46 (1H, ddd, Jꢂ10.3, 8.9,
5.5 Hz, xyl-4), 3.84 (1H, dd, Jꢂ11.3, 5.5 Hz, xyl-5), 4.09 (1H, qui,
Jꢂ6.6 Hz, H-5), 6.47 (1H, dd, Jꢂ7.9, 2.0 Hz, H-6ꢅ), 6.48 (H, dd, Jꢂ7.9,
2.0 Hz, H-6ꢄ), 6.60 (1H, d, Jꢂ2.0 Hz, H-2ꢅ), 6.61 (1H, d, Jꢂ2.0 Hz, H-2ꢄ),
6.63 (1H, d, Jꢂ7.9 Hz, H-5ꢅ), 6.64 (1H, d, Jꢂ7.9 Hz, H-5ꢄ). 13C-NMR data
are shown in Table 1.
Treatment of 5 with Acidic Methanol Fifty milligrams of 5 was dis-
solved in 5% HCl–MeOH (10 ml) and stood for 1 h. The reaction solution
was poured into 100 ml of ice-water and passed through a HP 20 column,
thoroughly washed with water, and eluted with methanol to give 35 mg of
product. The crude product was purified by preparative HPLC to give two
compounds, 4 (15 mg) and 12 (5 mg).
Extraction and Isolation Powdered leaves (1.0 kg) of A. japonica were
extracted with methanol under reflux to give a methanol extract, which
showed strong antioxidative activity. The MeOH extract was poured into
water and partitioned with ethyl acetate (AcOEt) and then n-butanol (n-
BuOH), to give an AcOEt layer, a n-BuOH layer and a water layer. The
AcOEt layer and the n-BuOH layer showed antioxidative activity. The n-
BuOH layer (35 g) was chromatographed on a SiO2 column using a gradient
CHCl3–MeOH solvent system to give nine fractions, AJMB-1—AJMB-9.
Of these fractions, AJMB-2 (6.1 g), AJMB-4 (3.7 g) and AJMB-4 (1.1 g)
showed potent activity. AJMB-2 and AJMB-3 were successively purified by
silica gel column chromatography and HPLC using a ODS column and 45%
CH3CN solvent to give 5 (2.9 g) and 11 (180 mg).
The AcOEt soluble fraction (90 g) was chromatographed on a silica gel
column using a gradient CHCl3–MeOH solvent system to give seven frac-
tions. Fr. 3 (6.2 g) was purified by repeated HPLC using a 30% CH3CN sol-
vent system to give 4 (180 mg). Fr. 4 (8.4 g) was purified by HPLC using an
ODS column and preparative TLC, successively to give 3 (88 mg), 6
(10 mg), 7 (43 mg), 8 (74 mg) and 9 (7 mg). Fr. 5 (14.7 g) was purified by re-
peated HPLC using an ODS column and preparative TLC, successively to
give 1 (38 mg), 2 (35 mg), 5 (390 mg), 9 (25 mg), 10 (170 mg) and 11
(45 mg). Fr. 6 (16.2 g) was purified by HPLC using an ODS column to give 5
(1.1 g).
Alnuside A (1): Colorless viscous liquid, HR-FAB-MS: m/z 463.1965
[MꢁH]ꢁ (Calcd 463.1968 for C24H31O9. [a]D ꢀ19.5° (cꢂ0.03, MeOH). 1H-
NMR (CD3OD): d 1.72 (1H, m, H-6), 1.77 (1H, m, H-6), 2.50 (2H, m, H-7),
2.57 (1H, dd, Jꢂ17.0, 5.5 Hz, H-4), 2.74 (4H, s, H-1, H-2), 2.79 (1H, dd,
Jꢂ17.0, 7.0 Hz, H-4), 3.12 (1H, dd, Jꢂ9.0, 7.5 Hz, xyl-2), 3.16 (1H, dd,
Jꢂ11.5, 10.0 Hz, xylH-5), 3.29 (1H, t, Jꢂ9.0 Hz, xyl-3), 3.47 (1H, ddd,
Jꢂ10.5, 8.5, 5.5 Hz, xyl-4), 3.86 (1H, dd, Jꢂ11.5, 5.5 Hz, xyl-5), 4.10 (1H,
br qui, Jꢂ5.0 Hz, H-5), 4.21 (1H, d, Jꢂ8.0 Hz, xyl-1), 6.47 (1H, dd, Jꢂ7.5,
2.0 Hz, H-6ꢅ), 6.60 (1H, d, Jꢂ2.0 Hz, H-2ꢅ), 6.64 (1H, d, Jꢂ7.5 Hz, H-5ꢅ),
6.67 (2H, d, Jꢂ8.5 Hz, H-3ꢄ, 5ꢄ), 6.99 (2H, d, Jꢂ8.5 Hz, H-2ꢄ, 6ꢄ). 13C-NMR
data are shown in Table 1.
Alnuside B (2): Colorless viscous liquid. HR-FAB-MS: m/z 463.1978
[MꢁH]ꢁ (Calcd 463.1968 for C24H31O9). [a]D ꢀ15.5° (cꢂ0.04, MeOH).
1H-NMR (CD3OD): d 1.72 (1H, m, H-6), 1.77 (1H, m, H-6), 2.5 (2H, m, H-
7), 2.57 (1H, dd, Jꢂ17.0, 5.5 Hz, H-4), 2.69 (2H, br t, Jꢂ5.5 Hz, H-2), 2.73
(2H, br t, Jꢂ5.5 Hz, H-1), 2.79 (1H, dd, Jꢂ17.0, 7.0 Hz, H-4), 3.12 (1H, dd,
Jꢂ9.0, 8.0 Hz, xyl-2), 3.16 (1H, dd, Jꢂ11.5, 10.0 Hz, xyl-5), 3.29 (1H, t,
Jꢂ9.0 Hz, xyl-3), 3.47 (1H, ddd, Jꢂ10.5, 8.5, 5.5 Hz, xyl-4), 3.84 (1H, dd,
Jꢂ11.5, 5.5 Hz, xyl-5), 4.10 (1H, br qui, Jꢂ5.0 Hz, H-5), 4.21 (1H, d,
Jꢂ8.0 Hz, xyl-1), 6.47 (1H, dd, Jꢂ7.5, 2.0 Hz, H-6ꢄ), 6.60 (1H, d, Jꢂ2.0 Hz,
H-2ꢄ), 6.64 (1H, d, Jꢂ7.5 Hz, H-4ꢄ), 6.67 (2H, d, Jꢂ8.5 Hz, H-3ꢅ, 5ꢅ), 6.99
(2H, d, Jꢂ8.6 Hz, H-2ꢅ, 6ꢅ). 13C-NMR data are shown in Table 1.
12: HR-FAB-MS: m/z 329.1379 [MꢁH]ꢁ (Calcd 329.1389, C19H21O5).
1H-NMR (CD3OD): d 2.46 (2H, br q, Jꢂ7.5 Hz, H-6), 2.61 (2H, t,
Jꢂ7.5 Hz, H-7), 2.71 (2H, t, Jꢂ7.0 Hz, H-2), 2.79 (2H, t, Jꢂ7.0 Hz, H-1),
6.06 (1H, d, Jꢂ15.5 Hz, H-4), 6.48, 6.49 (each 1H, dd, Jꢂ8.0, 1.5 Hz, H-6ꢄ,
6ꢅ), 6.60 (each 2H, d, Jꢂ1.5 Hz, H-2ꢄ, 2ꢅ), 6.65, 6.66 (each 1H, d, Jꢂ8.0 Hz,
H-5ꢄ, 5ꢅ), 6.87 (1H, dt, Jꢂ15.5, 7.5 Hz, H-5). 13C-NMR (CDCl3): d 30.9 (C-
6), 34.8 (C-7), 36.3 (C-2), 45.4 (C-1), 116.3ꢃ2, 116.5ꢃ2 (C-2ꢄ, 5ꢄ, 2ꢅ, 5ꢅ),
120.5, 120.6 (C-6ꢄ, 6ꢅ), 131.5 (C-4), 133.8, 134.0 (C-1ꢄ, 1ꢅ), 144.4, 144.5
(C-3ꢄ, 3ꢅ), 146.1, 146.2 (C-4ꢄ, 4ꢅ), 149.2 (C-5), 202.8 (C-3).
Treatment of 5 with Acidic Ethanol Fifty milligrams of 5 was dis-
olved in 3% HCl–EtOH (10 ml) and stood for 1 h. The reaction solution was
poured into 100 ml of ice-water and passed through a HP 20 column, thor-
oughly washed with water, and eluted with methanol to give 35 mg of prod-
uct. The crude product was purified by preparative HPLC (ODS column,
35% CH3CN) to give 12 (8 mg) and 13 (15 mg).
13: HR-FAB-MS: m/z 375.1777 [MꢁH]ꢁ (Calcd 375.1785, C21H27O6).
1H-NMR (CDCl3): d 1.11 (3H, t, Jꢂ7.0 Hz, CH3 of ethoxyl), 1.67 (2H, m,
H-6), 2.47 (2H, overlap, H-7), 2.49 (1H, overlap, H-4), 2.64 (1H, dd,
Jꢂ16.0, 6.0 Hz, H-4) 2.69 (4H, overlap, H-1, 2), 3.33 (2H, m, CH2 of
ethoxyl), 6.60, 6.61 (1H each, d, Jꢂ1.5 Hz, H-2ꢄ, 2ꢅ), 6.47, 6.48 (1H each,
dd, Jꢂ8.0, 1.5 Hz, H-6ꢄ, 6ꢅ), 6.65, 6.66 (1H each, d, Jꢂ8.0 Hz, H-5ꢄ, 5ꢅ).
13C-NMR (CDCl3): d 15.8 (CH3 of ethoxyl), 30.1 (C-1), 31.8 (C-7), 37.5 (C-
6), 46.8 (C-2), 48.8 (C-4), 65.6 (CH2 of ethoxyl), 76.4 (C-5), 116.3, 116.4
(C-5ꢄ, 5ꢅ), 116.5ꢃ2 (C-2ꢄ, 2ꢅ), 120.6ꢃ2 (C-6ꢄ, 6ꢅ), 134.1, 134.9 (C-1ꢄ, 1ꢅ),
144.3, 144.5 (C-3ꢄ, 3ꢅ), 146.2ꢃ2 (C-4ꢄ, 4ꢅ), 211.7 (C-3).
Acetylation of 5 Fifty-four milligrams of 5 was dissolved in pyridine
(1 ml) and acetic anhydride (1 ml) and stood for 4 h at room temperature.
The reaction solution was poured into ice-water and extracted with CHCl3.
The CHCl3 solution was washed successively with dil-HCl aq. soln, sat-
NaHCO3 aq. soln and water. The CHCl3 solution was evaporated to give
90 mg of crude product. The crude product was purified by preparative TLC
to give a per acetate (14) (60 mg).
1
14: MS: m/z 773 [MꢁH]ꢁ C38H44O17, H-NMR (CDCl3): d 1.83 (2H, m,
H-7), 2.01, 2.02, 2.04 (3H each, s, Ac on xyl), 2.27, 2.28 (6H each, s, Ac on
benzene rings), 2.40 (1H, dd, Jꢂ16.5, 4.0 Hz, H-4), 2.66 (1H, overlap, H-4),
2.67 (4H, overlap, H-1, 2), 3.32 (1H, dd, Jꢂ12.0, 9.5 Hz, xyl-5), 4.08 (1H,
dd, Jꢂ12.0, 5.0 Hz, xyl-5), 4.19 (1H, m, H-5), 4.55 (1H, d, Jꢂ7.0 Hz, xyl-
1), 4.86 (1H, dd, Jꢂ9.5, 7.0 Hz, xyl-2), 4.95 (1H, dt, Jꢂ5.0, 9.5 Hz, xyl-4),
5.17 (1H, t, Jꢂ9.5 Hz, xyl-3), 6.99 (1H, Jꢂ2.0 Hz, H-2ꢄ or 2ꢅ), 7.01 (1H, d,
Jꢂ2.0 Hz, H-2ꢅ or 2ꢄ), 7.02—7.10 (4H, overlap, H-5ꢄ, 6ꢄ, 5ꢅ, 6ꢅ). 13C-NMR
(CDCl3): d 20.6ꢃ3 (Mes of acetyl groups), 20.7ꢃ4 (Mes of acetyl groups),
28.6 (C-1), 30.3 (C-17), 36.4 (C-16), 45.0 (C-2), 47.5 (C-4), 62.2 (xyl-5),
69.1, 71.3, 71.9 (xyl-2, 3, 4), 75.3 (C-5), 168.2, 168.3ꢃ2, 168.4, 168.5,
168.8, 170.0 (COs of acetyl groups), 206.9 (C-3).
Alnuside C (3): Colorless viscous liquid. HR-FAB-MS: m/z 563.2490
[MꢁH]ꢁ (Calcd 563.2493 for C29H39O11). [a]D ꢀ15.6° (cꢂ0.04, MeOH).
1H-NMR (CD3OD): d 0.93 (3H, t, Jꢂ7.5 Hz, MeBu-4), 1.11 (3H, d,
Jꢂ7.0 Hz, MeBu-5), 1.48 (1H, m, MeBu-3), 1.55 (1H, m, H-6), 1.66 (1H,
m, MeBu-3), 1.68 (1H, m, H-6), 2.36 (1H, six, Jꢂ7.0 Hz, MeBu-2), 2.47
(3H, overlap, H-2, 4), 2.5 (2H, m, H-7), 2.64 (3H, overlap, H-1, 4), 3.19
(1H, dd, Jꢂ11.5, 10.0 Hz, xyl-5), 3.40 (1H, t, Jꢂ9.5 Hz, xyl-3), 3.53 (1H,
ddd, Jꢂ10.8, 8.5, 5.5 Hz, xyl-4), 3.88 (1H, dd, Jꢂ11.5, 5.5 Hz, xyl-5), 4.07
(1H, br qui, Jꢂ5.5 Hz, H-5), 4.39 (1H, d, Jꢂ7.2 Hz, xyl-1), 4.63 (1H, dd,
Jꢂ9.5, 7.5 Hz, xyl-2), 6.46 (1H, dd, Jꢂ8.5, 2.5 Hz, H-6ꢅ), 6.48 (1H, dd,
Jꢂ7.5, 2.5 Hz, H-6ꢄ), 6.59 (1H, d, Jꢂ2.5 Hz, H-2ꢅ), 6.60 (1H, d, Jꢂ2.5 Hz,
H-2ꢄ), 6.64 (1H, d, Jꢂ8.5 Hz, H-5ꢅ), 6.66 (1H, d, Jꢂ7.5 Hz, H-5ꢄ). 13C-
NMR data are shown in Table 1.
NaBH4 Reduction of 5 Sixty milligrams of 5 was dissolved in 10 ml of
MeOH, and 20 mg of NaBH4 was added and stirred for 1 h at room tempera-
ture. The reaction solution was poured into water and passed through a HP
20 column, washed with water and eluted with MeOH to give a MeOH elu-
ate (42 mg). The MeOH eluate was purified by HPLC (ODS column, 40%
CH3CN) to give two compounds 15a (9 mg) and 15b (7 mg). 15a and 15b
should be epimers at C-3 each other, but their configurations at C-3 of these
compound have not been determined.
5-O-Methylhirusutanonol (4): Colorless viscous liquid. FAB-MS: m/z 361
[MꢁH]ꢁ C20H25O6. [a]D ꢁ3.8° (cꢂ0.07, MeOH). 1H-NMR (CD3OD): d
1.65 (1H, m, H-6), 1.72 (1H, m, H-6), 2.45 (2H, m, H-7), 2.48 (1H, dd,
Jꢂ16.2, 5.4 Hz, H-4), 2.65 (1H, dd, Jꢂ16.2, 7.2 Hz, H-4), 2.68 (4H, br s, H-
1, 2), 3.25 (3H, s, OMe), 3.62 (1H, qui, Jꢂ6.6 Hz, H-5), 6.46 (1H, dd,
Jꢂ8.4, 1.8 Hz, H-6ꢅ), 6.48 (1H, dd, Jꢂ8.4, 1.8 Hz, H-6ꢄ), 6.59 (1H,
Jꢂ1.8 Hz, H-2ꢅ), 6.60 (1H, Jꢂ1.8 Hz, H-2ꢄ), 6.64 (1H, d, Jꢂ8.4 Hz, H-5ꢄ),
6.65 (1H, d, Jꢂ8.4 Hz, H-5ꢅ). 13C-NMR data are shown in Table 1.
Oregonin (5): Pale yellow viscous liquid. FAB-MS: m/z 479 [MꢁH]ꢁ
15a: FAB-MS: m/z 503 [MꢁH]ꢁ C24H33O10. 1H-NMR (CD3OD): d
1.61—1.82 (5H, m, overlap H-2, H-4, H-6), 2.46—2.61 (4H, m, overlap, H-
1, H-7), 3.15 (1H, dd, Jꢂ9.5, 7.5 Hz, xyl-2), 3.17 (1H, dd, Jꢂ11.5, 10.0 Hz,
xyl-5), 3.29 (1H, t, Jꢂ9.5 Hz, xyl-3), 3.49 (1H, ddd, Jꢂ10.5, 9.5, 5.5 Hz,
xyl-4), 3.67 (1H, m, H-3), 3.80 (1H, quin, Jꢂ6.5 Hz, H-5), 3.86 (1H, dd,
Jꢂ11.5, 5.5 Hz, xyl-5), 4.22 (1H, d, Jꢂ7.5 Hz, xyl-1), 6.48 (1H, dd, Jꢂ8.0,
2.0 Hz, H-6ꢄ or H-6ꢅ), 6.50 (1H, dd, Jꢂ8.0, 2.0 Hz, H-6ꢅ or H-67), 6.61 (1H,
d, Jꢂ2.0 Hz, H-2ꢄ or H-2ꢅ), 6.63 (1H, d, Jꢂ2.0 Hz, H-2ꢅ or H-2ꢄ), 6.64 (1H,
d, Jꢂ8.0 Hz, H-5ꢄ or H-5ꢅ), 6.66 (1H, d, Jꢂ8.0 Hz, H-5ꢅ or H-5ꢄ). 13C-NMR
(CD3OD): d 31.7, 32.2 (C-1, C-7), 38.7 (C-6), 41.2 (C-2), 43.0 (C-4), 67.0
1
C24H31O10. [a]D ꢀ16.9° (cꢂ0.12, MeOH). H-NMR (CD3OD): d 1.71 (1H,
m, H-6), 1.76 (1H, m, H-6ꢄ), 2.46 (1H, ddd, Jꢂ13.8, 9.6, 6.2 Hz, H-7), 2.53
(1H, ddd, Jꢂ13.8, 10.0, 5.3 Hz, H-7), 2.56 (1H, dd, Jꢂ16.8, 5.2 Hz, H-4),
2.70 (2H, overlap, H-1), 2.70 (2H, overlap, H-2), 2.78 (1H, dd, Jꢂ16.8,
6.8 Hz, H-4), 3.11 (1H, dd, Jꢂ9.2, 7.9 Hz, xyl-2), 3.16 (1H, dd, Jꢂ11.3,